Generic Ocuflox is used for treating and preventing eye infections associated with conjunctivitis (pink eye) and corneal ulcers caused by certain bacteria in patients 1 year of age and older.
Generic Famvir is used for treating herpes zoster infection (shingles). It is also used to treat recurring herpes skin infections in patients who also have HIV infection. Famvir is used in patients who have a weakened immune system to treat recurring cold sores and to treat or suppress recurring genital herpes.
Generic Relenza is used to treat flu symptoms caused by influenza virus in patients who have had symptoms for less than 2 days. It may also be given to prevent influenza in people who may be exposed but do not yet have symptoms. It will not treat the common cold.
Generic Symmetrel is an antiviral. It is used to prevent or treat certain influenza (flu) infections (type A). It may be given alone or along with flu shots. Generic Symmetrel will not work for colds, other types of flu or other virus infections. This medicine is also used to treat Parkinson's disease and other movement disorders.
Generic Tamiflu is used to treat flu symptoms caused by influenza virus types A and B in patients who have had symptoms for less than 2 days. It may also be given to prevent influenza in people who may be exposed but do not yet have symptoms.
Generic Valtrex is used for treating shingles (herpes zoster), cold sores (fever blisters or herpes labialis), and treating or suppressing genital herpes in patients with normal immune systems. It is also used to suppress genital herpes in patients with HIV infection.
Generic Zovirax is an antiviral drug. It slows the growth and spread of the herpes virus so that the body can fight off the infection. Acyclovir will not cure herpes, but it can lessen the symptoms of the infection. Acyclovir is used to treat infections caused by herpes viruses. Illnesses caused by herpes viruses include genital herpes, cold sores, shingles, and chicken pox.
Patients' Expectations About New HCV Direct-Acting Antivirals Often Unrealistic - Gastroenterology & Endoscopy News
Gastroenterology & Endoscopy NewsPatients' Expectations About New HCV Direct-Acting Antivirals Often UnrealisticGastroenterology & Endoscopy Newsby Christina Frangou San Francisco—Soon after the FDA approved two direct-acting antiviral agents (DAAs) last spring for treating infection with hepatitis C virus (HCV), a 57-year-old black man came to see gastroenterologist Andrew Muir, MD.
